Purpose: the aim of the study is to evaluate the presence of fatigue syndrome, the quality of life and functional ability of patients with bone and soft tissue sarcomas during the first 6 months of chemotherapy and identify possible prognostic factors.
Methods: prospective observational study was conducted. All patients about to start chemotherapy were consecutively recruited from July 2019 to April 2021.